https://idwiki.org/index.php?action=history&feed=atom&title=CR%3ADOI%3Ae5a504f06e86a949236f0995923d2dbc 2026-05-19T08:28:50Z Revision history for this page on the wiki MediaWiki 1.43.8 https://idwiki.org/index.php?title=CR:DOI:e5a504f06e86a949236f0995923d2dbc&diff=10831&oldid=prev 2024-09-27T17:09:24Z

<p>Created page with &quot;{{#scite: |reference=drayson2019le |type=journal-article |title=Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial |author=Mark T Drayson;Stella Bowcock;Tim Planche;Gulnaz Iqbal;Guy Pratt;Kwee Yong;Jill Wood;Kerry Raynes;Helen Higgins;Bryony Dawkins;David Meads;Claire T Hulme;Irene Monahan;Kamaraj Karunanithi;Helen Dignum;Edward Belsham;Jeff Neilson;Beth Harrison;Anand...&quot;</p> <p><b>New page</b></p><div>{{#scite:<br /> |reference=drayson2019le<br /> |type=journal-article<br /> |title=Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial<br /> |author=Mark T Drayson;Stella Bowcock;Tim Planche;Gulnaz Iqbal;Guy Pratt;Kwee Yong;Jill Wood;Kerry Raynes;Helen Higgins;Bryony Dawkins;David Meads;Claire T Hulme;Irene Monahan;Kamaraj Karunanithi;Helen Dignum;Edward Belsham;Jeff Neilson;Beth Harrison;Anand Lokare;Gavin Campbell;Michael Hamblin;Peter Hawkey;Anna C Whittaker;Eric Low;Janet A Dunn|+sep=;<br /> |journal=The Lancet Oncology<br /> |publisher=Elsevier BV<br /> |year=2019<br /> |volume=20<br /> |issue=12<br /> |pages=1760-1772<br /> |doi=10.1016/s1470-2045(19)30506-6<br /> |issn=1470-2045<br /> |retrieved-from=https://dx.doi.org/<br /> |retrieved-on=2024-09-27<br /> |@show=true<br /> }}</div>

Aidan